uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Development and evaluation of a pre-analytical device for liquid biopsy
2018 (English)Independent thesis Advanced level (professional degree), 20 credits / 30 HE creditsStudent thesis
Abstract [en]

In this project, a novel method to discover and monitor cancer was studied. Tumoureducated platelets (TEPs) have shown the ability to take up tumour-derived secretedmembrane vesicles, which contain tumour RNA. Therefore they are of great interestfor detecting cancer and could potentially work as biomarkers. One problem withusing blood platelets as a source of biomarkers is that clinical implementation isprevented by pre-analytical procedures that are difficult to perform in clinicallaboratories. In this study, human blood samples have been used to investigatewhether density gradient centrifugation followed by microfiltration could result inpure platelet (PLT) fractions. The idea is to enable parallel extraction of multiplesources of biomarkers from a single liquid biopsy, namely peripheral bloodmononuclear cells (PBMCs), PLTs and plasma. The procedure was done by firstresuspending the buffy coat in plasma after the centrifugation, where some cells werefixed and then filtered through a combination of membranes. From that, PLT fractionsfree from any nucleated cell could be obtained both for fixed and unfixed cells. Thenext step will be to detect tumour-specific transcripts in PLTs by investigatingwhether the purity of the extracted mRNA is sufficient for these kinds of procedures.This method holds great promise for creating a procedure to isolate, extract andanalyse several biomolecule fractions from a single liquid biopsy. Further studies couldinclude other biomarkers of interest such as circulating tumour DNA (ctDNA),extracellular vesicles (EVs) and plasma proteins.

Place, publisher, year, edition, pages
2018.
Series
UPTEC X ; 18 024
National Category
Engineering and Technology Biological Sciences
Identifiers
URN: urn:nbn:se:uu:diva-354483OAI: oai:DiVA.org:uu-354483DiVA, id: diva2:1221446
Educational program
Molecular Biotechnology Engineering Programme
Presentation
2018-06-14, B7:101A, BMC, 08:54 (English)
Supervisors
Examiners
Available from: 2018-06-25 Created: 2018-06-20 Last updated: 2018-06-25Bibliographically approved

Open Access in DiVA

The full text will be freely available from 2021-06-14 09:21
Available from 2021-06-14 09:21

Engineering and TechnologyBiological Sciences

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf